Skip to main content
OpenTrials

Clinical trial condition

Fallopian Tube Cancer

Explore clinical trials studying Fallopian Tube Cancer. Study availability and eligibility vary by location and protocol.

330 public trials 46 recruiting studies
Refine in advanced search Browse all conditions

Fallopian Tube Cancer trial results

Completed

Study of Safety & Biological Activity of IP IMNN-001 (also Known As GEN-1) with Neoadjuvant Chemo in Ovarian Cancer

NCT02480374

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • University of Alabama Birmingham Cancer Center Birmingham, Alabama, United States
  • Washington Univ. in St. Louis/Barnes Jewish Hospital St Louis, Missouri, United States
  • Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • Medical College of Wisconsin/Froedtert Hospital Milwaukee, Wisconsin, United States
View Trial Details
Completed

Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)

NCT03648489

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +22 more
Locations
  • Charité Universitätsmedizin Berlin Berlin, Germany
  • Universitätsklinikum Carl Gustav Carus Dresden Dresden, Germany
  • KEM Kliniken Essen-Mitte Essen, Germany
  • Furness General Hospital Barrow in Furness, Cumbria, United Kingdom
View all 15 locations
View Trial Details
Completed

A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression

NCT04296890

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Arizona Oncology Associates Phoenix, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • California Cancer Associates (cCARE) Fresno, California, United States
  • Stanford School of Medicine Palo Alto, California, United States
View all 89 locations
View Trial Details
Completed

Japan Phase 2 Study of Niraparib in Participants With Advanced, Relapsed Ovarian Cancer

NCT03759600

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Aichi Cancer Center Hospital Nagoya, Aichi-ken, Japan
  • Hirosaki University Hospital Hirosaki, Aomori, Japan
  • National Cancer Center Hospital East Kashiwa, Chiba, Japan
  • The Jikei University Kashiwa Hospital Kashiwa, Chiba, Japan
View all 33 locations
View Trial Details
Completed

Study of Mirvetuximab Soravtansine in Combination With Bevacizumab, Carboplatin, Pegylated Liposomal Doxorubicin, Pembrolizumab, or Bevacizumab + Carboplatin in Participants With Folate Receptor Alpha (FRα) Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Cancer

NCT02606305

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • University of California at Los Angeles Los Angeles, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • City of Hope Reno, Nevada, United States
View Trial Details
Completed

Japan Phase 2 Study of Niraparib (Maintenance Therapy) in Participants With Relapsed Ovarian Cancer

NCT03759587

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Aichi Cancer Center Hospital Nagoya, Aichi-ken, Japan
  • Hirosaki University Hospital Hirosaki, Aomori, Japan
  • Shikoku Cancer Center Matsuyama, Ehime, Japan
  • Ehime University Hospital Tōon, Ehime, Japan
View all 27 locations
View Trial Details
Completed

CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib

NCT04676334

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +29 more
Locations
  • London Regional Cancer Centre London, Ontario, Canada
  • Institut De Recherche De L'Hospital D'Ottawa Ottawa, Ontario, Canada
  • Princess Margaret Hospital - Toronto Toronto, Ontario, Canada
  • Centre Hospitalier de L'Universite de Montreal (CHUM) Montreal, Quebec, Canada
View all 25 locations
View Trial Details

Related conditions